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INTRODUCTION 
Vesiculobullous (VB) diseases are a group of oral 
disorders denoted by the development of vesicles or 
bullae. VB group of diseases comprise of 
mucocutaneous autoimmune diseases, viral diseases, 
diseases with immune modulated mechanisms, and 
genetically inherited diseases. The diagnosis of this 
disease is commonly made clinically with 
histopathological and immunofluorescence 
investigations.1,2 Benign Mucous Membrane 
Pemphigoid (MMP) is one of the VB diseases that 
mostly affect the mucous membranes. MMP is one of 
the rare diseases of oral mucous membrane with an 
incidence of 2-10 cases per 100,000 population.3,4   
 
The course of this disease is considered less severe 
compared to Pemphigus. In this disease, 
immunoglobulins, i.e., IgG, IgA, and IgM 
autoantibodies move towards the different antigens 
such as laminin 332, 311, targeting bullous antigen, 
collagen type-VII, α6 β4-integrin, and unidentified 
basal membrane zone antigens in the basement 
membrane.5,6 MMP is mostly prevalent in elderly 
females.6 Different mucosal sites can be involved, such 
as oral mucosa, oropharynx, larynx, ocular, and genital 
mucosa. Sometimes, it also appears on the skin mostly 
involved head, neck, and upper torso.1,3 The typical 
characteristic sign of MMP is the mucosal erosion, 
blister formation, and followed by scarring.1,6 Other 
intra-oral clinical features include vesicles, 
desquamative gingivitis, erosions covered by 
pseudomembranous slough, and ulcers.7 
 
 
 
CASE PRESENTATION 
A 48-year-old female patient reported to the outpatient 
department of Oral and Maxillofacial Pathology of 
Modern Dental College, Indore, India, with a chief 
complaint of ulcers in the mouth for eight months 
(Figure 1). She noticed the appearance of multiple 
ulcers on the right side of buccal mucosa that healed 
and reappeared after 10 to 15 days, mostly at the same 
site, preceded by boils that burst in 3-4 days. History of 
itching on the scalp was also present. The patient had 
no history of deleterious oral habits. No recent drug 
history was reported by the patient. She had no relevant 
family history.   
 
 
 
General Examination revealed that the patient was 
moderately built, cooperative. Vital signs were within 
the normal range, no sign of pallor in lower palpebral 
conjunctiva  and  nails , no  sign  of  edema and cyanosis  
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Figure 1. Clinical Appearance of the Patient 
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reported. The examination of lymph nodes showed 
bilateral submandibular lymphadenopathy. Extraoral 
examination showed that lips were competent, no 
abnormality was detected in TMJ’s, no sign of rash or 
erythema on the skin, and no gross facial asymmetry. 
Areas of excoriation were present on the scalp.  
 
Intraoral soft tissue examination revealed a grayish-
white lesion on the right buccal mucosa with diffuse 
borders. The lesion was extending anteroposteriorly 
from the commissure of lips to the retromolar area, 
superior-inferiorly in the upper and lower buccal 
vestibule, and interspersed with minute pinpoint ulcers 
of 0.5 to 2mm in size (Figure 2). Localized 
desquamation of marginal gingiva was present 
concerning 45, 46, 47 teeth (Figure 3). The entire lesion 
was scrapable. However, tissue tags remained with 
bleeding and tender. Intraoral hard tissue examination 
showed that patient had missing teeth, i.e., 16, 17, 26, a 
carious tooth with 46, occlusal facets on 36, 37, 46 teeth 
and generalized calculus and gingival inflammation. 
Based on the above-mentioned clinical findings, a 
provisional diagnosis of Erosive lichen planus and 
differential diagnosis of Vesiculobulouos Lichen 
planus, Pemphigus, and Pemphigoid were given. 
 
 
 
 
 
The patient had undergone haematological and urine 
examination. Blood examination revealed average 
values for haemoglobin, haematocrit, bleeding, and 
clotting time, and blood sugar level. The urine analysis 
report was also found negative. An incisional biopsy 
specimen was obtained. The specimen was firm in 
consistency, irregular in shape, and 1.1 x 0.3 x 0.2 cm in 
size and examined for histopathological features 
(Figure 4). Histopathology highlighted parakeratinized 
stratified squamous epithelium of different thicknesses 
with subepithelial split and degeneration of basal cells  
 
 
 
 
 
in some areas. Inflammatory cell infiltrates, 
eosinophils, and vascularity seen in connective tissue 
stroma (Figure 5). A final definitive diagnosis of benign 
mucous membrane pemphigoid was given based on the 
clinical findings and investigations. The patient was 
prescribed triamcinolone acetonide steroid ointment 
for topical application three times a day and recalled 
after one month. Improvement was observed after four 
weeks of steroid application, and then the patient was 
asked to taper the dose. 
 
 
 
 
 
DISCUSSION 
Benign mucous membrane pemphigoid is a group of 
chronic blistering, mucocutaneous autoimmune 
diseases in which autoantibodies move against one or 
more components of the basement membrane. The first 
case of MMP was reported in 1794 by Wickmann.8 The 
exact etiology of MMP is still not clear. There are many 
possible   etiological   risk    factors    such    as     severe  
 
Figure 2. Clinical Examination of the Lesion 
Figure 3. Presence of Localized 
Desquamation of Marginal Gingiva with 
respect to 45, 46, 47  
Figure 4. Specimen Obtained for Incisional Biopsy 
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inflammatory injury of the mucosa, drugs (D-
penicillamine, indomethacin, clonidine), virus, 
ultraviolet rays, and genetic susceptibility (biomarker 
HLA DQB1*03:01) have been reported in the existing 
literature.9 MMP is an autoimmune, VB lesion in which 
cytokines and leukocyte enzymes release through 
complement system by sequestration of neutrophil and 
followed by cell lysis possibly from complement system, 
results in loss of adhesion of basal cell-basement 
membrane leading to the formation of a vesicle under 
the epithelium.10 Body induced a specific protein such 
as 168-KDa, α6 integrin which is found exclusively in 
oral mucous membrane pemphigoid.11  
 
MMP occurs mostly between 40 and 50 years, and 
females are affected more frequently than males by a 2:1 
ratio. Oral lesions are the typical characteristic feature 
seen in most of the patients. It affects mostly oral 
mucosa (85%), and other mucosae such as nasal 
mucosa, oropharynx, conjunctiva, and genital 
mucosa.12-15 Oral lesions of pemphigoid begin as either 
vesicles or bullae. The oral blisters rupture, leaving 
large, superficial, ulcerated, and denuded areas of 
mucosa. The ulcerated lesions are usually painful and 
persist for weeks to months if untreated. Gingival 
involvement produces a clinical reaction pattern 
termed desquamative gingivitis.16 The lesion healed 
with a scar and followed by hyperpigmentation.15 In 
some cases, complications such as hoarseness of voice, 
ocular defect, and airway obstruction may occur.12,15 
Skin lesions are not much common and mostly found 
on the face, neck, scalp, abdomen, and limbs.17 
 
The biopsy of   the lesion  shows  a  split  between  the  
surface epithelium and the underlying connective 
tissue. A mild chronic inflammatory cell infiltrate is 
present in the superficial submucosa. Direct 
immunofluorescence studies show a continuous linear 
band of immunoreactions at the basement membrane 
zone. The immune deposits consist primarily of IgG and 
C3, although IgA and IgM may also be identified.18 The 
topical application of steroids on the lesion is advised. 
If topical steroids are unsuccessful, systemic steroids 
plus other immunosuppressive agents can be 
prescribed.  
 
CONCLUSION: 
Based on the different clinical evidence and 
histopathological findings, mucous membrane 
pemphigoid resembles a variety of diseases. The 
investigations for differentiating various types of 
pemphigoid are specific, expensive, and not routinely 
used. Therefore, this entity requires a comprehensive 
clinical, and histopathological evaluation. Early 
detection and prompt treatment recommended 
avoiding potential complications. 
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